Goldman Sachs is optimistic about Chinese medical stocks, expecting trading opportunities in the post-AI era
2026-09-13 20:04:15
According to CoinMeta, as reported by CNBC, Goldman Sachs has identified Chinese medical stocks as trading opportunities in the post-AI era. The returns on Chinese stocks tracked by Goldman Sachs have seen the fastest quarterly growth in five years.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.